Abstract
Background Warts are tumors or growths caused by infection with Human Papilloma virus (HPV). Currently, over 170 HPV types have been identified. Objective This study aimed to evaluate the efficacy and safety of intralesional injection of methotrexate for the treatment of plantar warts. Patients and Methods Sixty patients presented with plantar warts were divided into 2 groups. Group A patients were injected with intralesional methotrexate (MTX) (2 mg/ml). Group B patients were injected with intralesional saline as a placebo. The injections were repeated every week for a maximum of 6 sessions or until complete clearance, whichever was earlier. The patients were followed up for 6 months after the last injection. Results In the intralesional MTX group, 2 patients (6.7%) showed complete improvement, 8 patients (26.7%) showed partial improvement and 20 patients (66.7%) showed no improvement. In the intralesional saline group, 3 patients (10%) showed complete improvement, 4 patients (13.3%) showed partial improvement and 23 patients (76.7%) showed no improvement. Reported adverse events were local reactions in the form of swelling, pain, and infection in both groups. Conclusion There was no statistically significant difference between the therapeutic responses to intralesional MTX injection and saline.

This publication has 12 references indexed in Scilit: